Picture of Waters logo

WAT — Waters News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Scotiabank upgrades Waters to 'sector outperform', raises PT

** Brokerage Scotiabank upgrades life sciences tool maker
Waters Corp  WAT.N  rating to "sector outperform" from "sector
perform", raises PT to $450 from $430 
    ** Brokerage says the rating is based on WAT's strong Q4
financial performance and 2025 profit forecast 
    ** The price target is justified due to the timing of its
clients' instrument replacement cycles, significant revenue from
life science applications, and a leading position in emerging
markets such as GLP-1 obesity drugs and generic drugs in India -
Scotiabank
    ** "On the bottom line, WAT continues to have significant
EPS leverage, driven by its industry leading margins, recently
initiated productivity and pricing initiatives and cash
deployment capacity" - brokerage 
    ** Stock rose 21.7% in the last 12 months 

 (Reporting by Padmanabhan Ananthan)
 ((Padmanabhan.Ananthan@thomsonreuters.com;))

Recent news on Waters

See all news